Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice

BACKGROUND: Several studies stablished a relationship between metabolic disturbances and Alzheimer´s disease (AD) where inflammation plays a pivotal role. However, mechanisms involved still remain unclear. In the present study, we aimed to evaluate central and peripheral effects of dexibuprofen (DXI...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Biosci
Egile Nagusiak: Ettcheto, Miren, Sánchez-Lopez, Elena, Cano, Amanda, Carrasco, Marina, Herrera, Katherine, Manzine, Patricia R., Espinosa-Jimenez, Triana, Busquets, Oriol, Verdaguer, Ester, Olloquequi, Jordi, Auladell, Carme, Folch, Jaume, Camins, Antoni
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2021
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8296685/
https://ncbi.nlm.nih.gov/pubmed/34294142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-021-00646-w
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak